Prognostic value of PD-L1 expression in patients with pancreatic cancer: A PRISMA-compliant meta-analysis

BACKGROUND: Programmed cell death ligand 1 (PD-L1) expression was reported to be associated with poor prognosis in various solid tumors. However, the prognosis value of PD-L1 in pancreatic cancer remained inconclusive. We performed a meta-analysis to assess the clinical value of PD-L1 as a novel pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ying, Chen, Wanzhen, Yan, Zhanpeng, Ma, Jingxia, Zhu, Fangshi, Huo, Jiege
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370132/
https://www.ncbi.nlm.nih.gov/pubmed/30653106
http://dx.doi.org/10.1097/MD.0000000000014006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370132/
https://www.ncbi.nlm.nih.gov/pubmed/30653106
http://dx.doi.org/10.1097/MD.0000000000014006

Ejemplares similares